MA26993A1 - 6-pyridopyrimidines substitues - Google Patents

6-pyridopyrimidines substitues

Info

Publication number: MA26993A1
Authority: MA; Morocco
Prior art keywords: pyridopyrimidines; substituted; substituted pyridopyrimidines
Prior art date: 2001-02-12

Application number

MA27273A

Other languages

English (en)

Inventor

Jian Jeffrey Chen

James Patrick Dunn

David Michael Goldstein

Christoph Martin Stahl

Original Assignee

Hoffmann La Roche

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-02-12

Filing date

2003-08-11

Publication date

2004-12-20

2003-08-11 Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche

2004-12-20 Publication of MA26993A1 publication Critical patent/MA26993A1/fr

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D519/00—Heterocyclic compounds containing more than one system of two or more relevant hetero rings condensed among themselves or condensed with a common carbocyclic ring system not provided for in groups C07D453/00 or C07D455/00

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Rheumatology (AREA)
Immunology (AREA)
Dermatology (AREA)
Orthopedic Medicine & Surgery (AREA)
Psychiatry (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Hospice & Palliative Care (AREA)
Physical Education & Sports Medicine (AREA)
Heart & Thoracic Surgery (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

MA27273A 2001-02-12 2003-08-11 6-pyridopyrimidines substitues MA26993A1 (fr)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US26837501P	2001-02-12	2001-02-12
US33465401P	2001-11-30	2001-11-30

Publications (1)

Publication Number	Publication Date
MA26993A1 true MA26993A1 (fr)	2004-12-20

Family

ID=26953040

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA27273A MA26993A1 (fr)	2001-02-12	2003-08-11	6-pyridopyrimidines substitues

Country Status (31)

Country	Link
US (3)	US6696566B2 (fr)
EP (1)	EP1361880B1 (fr)
JP (1)	JP4064818B2 (fr)
KR (1)	KR100639772B1 (fr)
CN (1)	CN100376571C (fr)
AR (1)	AR035854A1 (fr)
AT (1)	ATE305303T1 (fr)
AU (1)	AU2002256615B2 (fr)
BR (1)	BRPI0207172B8 (fr)
CA (1)	CA2434834C (fr)
CZ (1)	CZ20032416A3 (fr)
DE (1)	DE60206363T2 (fr)
DK (1)	DK1361880T3 (fr)
ES (1)	ES2249574T3 (fr)
HR (1)	HRP20030624B1 (fr)
HU (1)	HU229604B1 (fr)
IL (2)	IL156872A0 (fr)
JO (1)	JO2410B1 (fr)
MA (1)	MA26993A1 (fr)
MX (1)	MXPA03007166A (fr)
MY (1)	MY131518A (fr)
NO (1)	NO326133B1 (fr)
NZ (1)	NZ526961A (fr)
PA (1)	PA8539201A1 (fr)
PE (1)	PE20020976A1 (fr)
PL (1)	PL366918A1 (fr)
RU (1)	RU2269527C2 (fr)
SK (1)	SK11322003A3 (fr)
WO (1)	WO2002064594A2 (fr)
YU (1)	YU63703A (fr)
ZA (1)	ZA200305938B (fr)

Families Citing this family (42)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7053070B2 (en) *	2000-01-25	2006-05-30	Warner-Lambert Company	Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
ATE305303T1 (de)	2001-02-12	2005-10-15	Hoffmann La Roche	6-substituierte pyridopyrimidine
GEP20063909B (en) *	2002-01-22	2006-08-25	Warner Lambert Co	2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d] PYRIMIDIN-7-ONES
PL374544A1 (en)	2002-04-03	2005-10-31	F.Hoffmann-La Roche Ag	Imidazo fused compounds
RU2324695C2 (ru) *	2002-08-06	2008-05-20	Ф.Хоффманн-Ля Рош Аг	6-АЛКОКСИПИРИДОПИРИМИДИНЫ И ФАРМАЦЕВТИЧЕСКАЯ КОМПОЗИЦИЯ, ОБЛАДАЮЩАЯ АКТИВНОСТЬЮ ИНГИБИТОРОВ КИНАЗЫ МАР р38
JP2006516548A (ja)	2002-12-30	2006-07-06	アンジオテックインターナショナルアクツィエンゲゼルシャフト	迅速ゲル化ポリマー組成物からの薬物送達法
US7230098B2 (en) *	2003-02-26	2007-06-12	Sugen, Inc.	Aminoheteroaryl compounds as protein kinase inhibitors
EP1620105B1 (fr) *	2003-04-16	2007-01-10	F. Hoffmann-La Roche Ag	Derives amines de (6-(phenoxy)-pyrido ¬3,4-d\| pyrimidin-2-yle) en tant qu'inhibiteurs de la kinase p38 pour le traitement de conditions inflammatoires telles que la polyarthrite rhumatoide
SI1685131T1 (sl) *	2003-11-13	2007-06-30	Hoffmann La Roche	Hidroksialkil-substituirani pirido-7-pirimidin-7-oni
WO2006056863A1 (fr) *	2004-11-23	2006-06-01	Ranbaxy Laboratories Limited	Pyrido'2, 3-d!pyrimidines utilisees comme agents anti-inflammatoires
US20060142312A1 (en) *	2004-12-23	2006-06-29	Pfizer Inc	C6-aryl and heteroaryl substituted pyrido[2,3-D] pyrimidin-7-ones
EP1846403A1 (fr) *	2005-02-02	2007-10-24	Ranbaxy Laboratories Limited	Derives azabicyclo utilises comme agents anti-inflammatoires
WO2006119504A2 (fr) *	2005-05-04	2006-11-09	Renovis, Inc.	Composes heterocycliques fusionnes, leurs compositions et leurs utilisations
MX2008000885A (es) *	2005-07-21	2008-03-18	Hoffmann La Roche	Compuestos de pirido[2,3-d]pirimidin-2,4-diamina como inhibidores de la proteina tirosina fosfatasa 1b.
CA2617359A1 (fr) *	2005-08-09	2007-02-22	Irm Llc	Composes et compositions utiles comme inhibiteurs de proteines kinases
WO2007022946A1 (fr)	2005-08-21	2007-03-01	Abbott Gmbh & Co. Kg	Composes heterocycliques et leur utilisation en tant que partenaires de liaison des recepteurs 5-ht5
JO2783B1 (en) *	2005-09-30	2014-03-15	نوفارتيس ايه جي	Compounds 2-Amino-7, 8-dihydro-6H-Bayredo (3,4-D) Pyrimidine-5-Ones
MX2008014908A (es) *	2006-05-26	2009-05-13	Toyama Chemical Co Ltd	Compuesto heterociclico nuevo o sal del mismo e intermedio del mismo.
WO2008150260A1 (fr) *	2007-06-06	2008-12-11	Gpc Biotech, Inc.	Inhibiteurs de kinase
WO2008078249A1 (fr) *	2006-12-21	2008-07-03	Ranbaxy Laboratories Limited	Agents anti-inflammatoires
US8022085B2 (en)	2007-05-07	2011-09-20	Amgen Inc.	Pyrazolo-pyridinone and pyrazolo-pyrazinone compounds as P38 modulators and methods of use thereof
CN101679211A (zh)	2007-06-15	2010-03-24	霍夫曼-拉罗奇有限公司	用于制备3-氨基-戊-1,5-二醇的新方法
US8367671B2 (en)	2008-03-21	2013-02-05	Amgen Inc.	Pyrazolo[3.4-B]pyrazine compounds as p38 modulators and methods of use as anti-inflamatory agents
EP2112150B1 (fr)	2008-04-22	2013-10-16	Forma Therapeutics, Inc.	Inhibiteurs Raf améliorés
EP2344502A2 (fr) *	2008-10-22	2011-07-20	F. Hoffmann-La Roche AG	Inhibiteurs pyrimidinylpyridone de jnk
WO2010071846A2 (fr)	2008-12-19	2010-06-24	Afraxis, Inc.	Composés pour traiter des états neuropsychiatriques
JP2013507395A (ja) *	2009-10-09	2013-03-04	アフラクシス・インコーポレイテッド	Ｃｎｓ障害治療用の８−エチル−６−（アリール）ピリド［２，３−ｄ］ピリミジン−７（８ｈ）−オン
KR101754664B1 (ko)	2009-12-18	2017-07-06	템플 유니버시티-오브 더 커먼웰쓰 시스템 오브 하이어 에듀케이션	치환된 피리도〔2,3-ｄ〕피리미딘-7(8ｈ)-온스 및 이의 치료 용도
WO2016015597A1 (fr)	2014-07-26	2016-02-04	Sunshine Lake Pharma Co., Ltd.	Composés utilisés comme petits molécules inhibitrices de cdk et leurs utilisations
SG11201809882XA (en)	2016-06-08	2018-12-28	Support Venture Gmbh	Pharmaceutical combinations for treating cancer
UA124804C2 (uk)	2016-08-15	2021-11-24	Пфайзер Інк.	Піридопіримідинонові інгібітори cdk2/4/6
CN109562105A (zh) *	2016-08-17	2019-04-02	企业支持有限责任公司	预防或治疗听力损失的方法
US11117858B2 (en)	2017-01-11	2021-09-14	The General Hospital Corporation	Voltage gated sodium channel imaging agents
SG10202110804WA (en) *	2017-04-04	2021-11-29	Kinarus Ag	Methods of preventing or treating ophthalmic diseases
CN111032655B (zh)	2017-08-31	2022-09-02	达纳-法伯癌症研究所股份有限公司	Egfr和/或her2抑制剂和使用方法
US10342786B2 (en)	2017-10-05	2019-07-09	Fulcrum Therapeutics, Inc.	P38 kinase inhibitors reduce DUX4 and downstream gene expression for the treatment of FSHD
EP3692144A1 (fr)	2017-10-05	2020-08-12	Fulcrum Therapeutics, Inc.	Utilisation d'inhibiteurs de p38 pour réduire l'expression de dux4
WO2020006210A1 (fr) *	2018-06-27	2020-01-02	Tufts Medical Center, Inc.	Composés pyridopyrimidine et leurs méthodes d'utilisation
CN112512586A (zh)	2018-07-13	2021-03-16	基纳鲁斯股份公司	用于预防或治疗纤维化疾病的ppar激动剂和p38激酶抑制剂的组合
TW202112368A (zh)	2019-06-13	2021-04-01	荷蘭商法西歐知識產權股份有限公司	用於治療有關dux4表現之疾病的抑制劑組合
WO2022034031A1 (fr)	2020-08-11	2022-02-17	Kinarus Ag	Procédés de prévention ou de traitement de covid-19 et de maladies ou troubles viraux associés
CN120247910A (zh) *	2025-04-01	2025-07-04	赣南师范大学	一种杂环类化合物及其制备方法、应用和防治肿瘤的药物组合物

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4215216A (en)	1979-04-18	1980-07-29	American Home Products Corporation	7,8-Dihydro-2,5,8-trisubstituted-7-oxo-pyrido[2,3-d]pyrimidine-6-carboxylic acid derivatives
US5037826A (en)	1986-10-15	1991-08-06	Schering Corporation	1-substituted naphthyridine and pyridopyrazine derivatives
GB8702758D0 (en) *	1987-02-06	1987-03-11	Wellcome Found	Treatment of disease
EP0278686A1 (fr)	1987-02-07	1988-08-17	The Wellcome Foundation Limited	Pyridopyrimidines, leurs procédés de préparation et compositions pharmaceutiques les contenant
ATE194985T1 (de) *	1990-11-06	2000-08-15	Yamanouchi Pharma Co Ltd	Kondensiertes pyrazinderivat
WO1993017682A1 (fr)	1992-03-04	1993-09-16	Abbott Laboratories	Antagonistes des recepteurs de l'angiotensine ii
TW299333B (fr) *	1992-12-29	1997-03-01	Takeda Pharm Industry Co Ltd
ES2146782T3 (es)	1994-11-14	2000-08-16	Warner Lambert Co	6-aril-pirido(2,3-d)pirimidinas y naftiridinas para la inhibicion de la proliferacion celular inducida por la proteina tirosina quinasa.
IL115256A0 (en) *	1994-11-14	1995-12-31	Warner Lambert Co	6-Aryl pyrido (2,3-d) pyrimidines and naphthyridines and their use
US5620981A (en)	1995-05-03	1997-04-15	Warner-Lambert Company	Pyrido [2,3-D]pyrimidines for inhibiting protein tyrosine kinase mediated cellular proliferation
IL117923A (en) *	1995-05-03	2000-06-01	Warner Lambert Co	Anti-cancer pharmaceutical compositions containing polysubstituted pyrido¬2,3-d¾pyrimidine derivatives and certain such novel compounds
AR004010A1 (es)	1995-10-11	1998-09-30	Glaxo Group Ltd	Compuestos heterociclicos
US6107300A (en)	1996-03-27	2000-08-22	Dupont Pharmaceuticals	Arylamino fused pyrimidines
US6147080A (en) *	1996-12-18	2000-11-14	Vertex Pharmaceuticals Incorporated	Inhibitors of p38
ES2301194T3 (es)	1997-02-05	2008-06-16	Warner-Lambert Company Llc	Pirido 2,3-d pirimidinas y 4-aminopirimidinas como inhibidores de la proliferacion celular.
US5945422A (en)	1997-02-05	1999-08-31	Warner-Lambert Company	N-oxides of amino containing pyrido 2,3-D! pyrimidines
TW458977B (en) *	1997-04-16	2001-10-11	Abbott Lab	6,7-disubstituted-4-aminopyrido[2,3-D] pyrimidine compounds
HUP0001434A3 (en)	1997-04-16	2001-01-29	Abbott Lab	5,7-disubstituted 4-aminopyrido[2,3-d]pyrimidine compounds, pharmaceutical compouads thereof and process for their preparation
WO1998046604A1 (fr)	1997-04-16	1998-10-22	Abbott Laboratories	Composes de 4-aminopyridol[2,3-d]pyrimidine a trisubstitution 5,6,7
CN1138778C (zh)	1998-05-26	2004-02-18	沃尼尔·朗伯公司	用作细胞增殖抑制剂的二环嘧啶及二环3,4-二氢嘧啶化合物及用途
PT1087970E (pt)	1998-06-19	2004-06-30	Pfizer Prod Inc	Compostos pirrolo¬2,3-d\|pirimidina
EP1078923B1 (fr)	1999-08-02	2006-03-08	F. Hoffmann-La Roche Ag	Procédé de préparation de dérivés de benzothiophène
US7053070B2 (en) *	2000-01-25	2006-05-30	Warner-Lambert Company	Pyrido[2,3-d]pyrimidine-2,7-diamine kinase inhibitors
DZ3308A1 (fr) *	2000-03-06	2001-09-27	Warner Lambert Co	Inhibiteurs de tyrosine kinase a base de 5-alkylpyrido [2,3-d] pyrimidines
US6518276B2 (en) *	2000-08-31	2003-02-11	Syntex (U.S.A.) Llc	7-oxo-pyridopyrimidines (II)
ATE305303T1 (de) *	2001-02-12	2005-10-15	Hoffmann La Roche	6-substituierte pyridopyrimidine
GEP20063909B (en) *	2002-01-22	2006-08-25	Warner Lambert Co	2-(PYRIDIN-2-YLAMINO)-PYRIDO[2,3d] PYRIMIDIN-7-ONES

2002
- 2002-02-04 AT AT02726103T patent/ATE305303T1/de active
- 2002-02-04 MX MXPA03007166A patent/MXPA03007166A/es active IP Right Grant
- 2002-02-04 WO PCT/EP2002/001106 patent/WO2002064594A2/fr not_active Ceased
- 2002-02-04 AU AU2002256615A patent/AU2002256615B2/en not_active Expired
- 2002-02-04 HR HR20030624A patent/HRP20030624B1/xx not_active IP Right Cessation
- 2002-02-04 YU YU63703A patent/YU63703A/sh unknown
- 2002-02-04 ES ES02726103T patent/ES2249574T3/es not_active Expired - Lifetime
- 2002-02-04 CN CNB028048342A patent/CN100376571C/zh not_active Expired - Lifetime
- 2002-02-04 DE DE60206363T patent/DE60206363T2/de not_active Expired - Lifetime
- 2002-02-04 HU HU0303458A patent/HU229604B1/hu unknown
- 2002-02-04 JP JP2002564525A patent/JP4064818B2/ja not_active Expired - Lifetime
- 2002-02-04 DK DK02726103T patent/DK1361880T3/da active
- 2002-02-04 CZ CZ20032416A patent/CZ20032416A3/cs unknown
- 2002-02-04 SK SK11322003A patent/SK11322003A3/sk unknown
- 2002-02-04 EP EP02726103A patent/EP1361880B1/fr not_active Expired - Lifetime
- 2002-02-04 KR KR1020037010562A patent/KR100639772B1/ko not_active Expired - Lifetime
- 2002-02-04 RU RU2003125887/04A patent/RU2269527C2/ru not_active IP Right Cessation
- 2002-02-04 PL PL02366918A patent/PL366918A1/xx not_active Application Discontinuation
- 2002-02-04 IL IL15687202A patent/IL156872A0/xx unknown
- 2002-02-04 BR BR0207172-0 patent/BRPI0207172B8/pt not_active IP Right Cessation
- 2002-02-04 NZ NZ526961A patent/NZ526961A/en unknown
- 2002-02-04 CA CA2434834A patent/CA2434834C/fr not_active Expired - Lifetime
- 2002-02-06 JO JO200212A patent/JO2410B1/en active
- 2002-02-08 PE PE2002000097A patent/PE20020976A1/es not_active Application Discontinuation
- 2002-02-08 PA PA20028539201A patent/PA8539201A1/es unknown
- 2002-02-11 AR ARP020100430A patent/AR035854A1/es unknown
- 2002-02-11 MY MYPI20020491A patent/MY131518A/en unknown
- 2002-02-11 US US10/073,845 patent/US6696566B2/en not_active Expired - Lifetime
2003
- 2003-07-10 IL IL156872A patent/IL156872A/en unknown
- 2003-07-31 ZA ZA2003/05938A patent/ZA200305938B/en unknown
- 2003-08-11 MA MA27273A patent/MA26993A1/fr unknown
- 2003-08-11 NO NO20033540A patent/NO326133B1/no not_active IP Right Cessation
- 2003-11-25 US US10/722,703 patent/US7169794B2/en not_active Expired - Lifetime
2007
- 2007-01-09 US US11/651,302 patent/US7449581B2/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
MXPA03007166A (es)	2003-11-18
HRP20030624B1 (en)	2007-03-31
RU2003125887A (ru)	2005-03-20
KR20040018254A (ko)	2004-03-02
NO20033540D0 (no)	2003-08-11
US6696566B2 (en)	2004-02-24
CN1503672A (zh)	2004-06-09
YU63703A (sh)	2006-05-25
EP1361880B1 (fr)	2005-09-28
JP2004525896A (ja)	2004-08-26
PL366918A1 (en)	2005-02-07
BRPI0207172B8 (pt)	2021-05-25
PA8539201A1 (es)	2004-08-31
IL156872A (en)	2009-07-20
ZA200305938B (en)	2005-01-26
SK11322003A3 (en)	2004-10-05
WO2002064594A2 (fr)	2002-08-22
US7449581B2 (en)	2008-11-11
ATE305303T1 (de)	2005-10-15
BRPI0207172B1 (pt)	2019-04-09
NZ526961A (en)	2005-03-24
US20070135458A1 (en)	2007-06-14
BR0207172A (pt)	2004-03-30
MY131518A (en)	2007-08-30
CZ20032416A3 (cs)	2004-07-14
HRP20030624A2 (en)	2005-06-30
CA2434834A1 (fr)	2002-08-22
JP4064818B2 (ja)	2008-03-19
US20030171584A1 (en)	2003-09-11
AU2002256615B2 (en)	2007-09-13
WO2002064594A3 (fr)	2003-01-09
DE60206363D1 (de)	2006-02-09
US7169794B2 (en)	2007-01-30
JO2410B1 (en)	2007-06-17
US20040116698A1 (en)	2004-06-17
EP1361880A2 (fr)	2003-11-19
HU229604B1 (en)	2014-02-28
NO20033540L (no)	2003-08-11
AR035854A1 (es)	2004-07-21
CN100376571C (zh)	2008-03-26
NO326133B1 (no)	2008-10-06
CA2434834C (fr)	2010-09-14
HK1066170A1 (en)	2005-03-18
ES2249574T3 (es)	2006-04-01
RU2269527C2 (ru)	2006-02-10
IL156872A0 (en)	2004-02-08
KR100639772B1 (ko)	2006-10-30
DE60206363T2 (de)	2006-07-06
HUP0303458A3 (en)	2012-12-28
DK1361880T3 (da)	2006-01-23
HUP0303458A2 (hu)	2004-01-28
PE20020976A1 (es)	2002-10-29

Publication	Publication Date	Title
MA26993A1 (fr)	2004-12-20	6-pyridopyrimidines substitues
DE60230584D1 (de)	2009-02-12	Fensterheber
IS7291A (is)	2004-06-01	Merkt kirni
ATE402148T1 (de)	2008-08-15	Substituierte pyridinylamine
PT1406628E (pt)	2006-06-30	Derivados de tera-hidroquinolina
ATE312827T1 (de)	2005-12-15	3-substituierte-4-pyrimidonderivate
DE60213088D1 (de)	2006-08-24	Chromen-verbindungen
DE50206892D1 (de)	2006-06-29	Substituierte imidazotriazinone
DE50207739D1 (de)	2006-09-14	Kombinationswerkzeug
DK1373228T3 (da)	2008-08-04	Substituerede fluoralkoxyphenylsulfonylurinstoffer
DE60213695D1 (de)	2006-09-21	Differentialeinheit
DE60223031D1 (de)	2007-11-29	Arylpiperazin gebundene tetrahydroindolonderivate
ATE435197T1 (de)	2009-07-15	Substituierte 4-aminocyclohexanole
DK1467802T3 (da)	2005-11-14	Nedfiringsanordning
DE50212426D1 (de)	2008-08-14	Bohrwerkzeug
ATA18372001A (de)	2005-07-15	Gelenksbolzenbaueinheit
ATE319694T1 (de)	2006-03-15	Phenylalkyne
DE60202381D1 (de)	2005-01-27	Paroxetin-n-formyl-derivate
ATA13992002A (de)	2003-10-15	Schlackengranulierungsanlage
FR2831227B1 (fr)	2004-10-22	Leve-vitre
DE60216967D1 (de)	2007-02-01	Substituierte cyclohexanderivate
ATA7462001A (de)	2002-01-15	Radspannwerk
ATA6162001A (de)	2002-11-15	Schneekette
UA5833S (uk)	2002-04-15	Знак розрізнення
FI5169U1 (fi)	2001-12-18	Ikkunalaudan leventävä kukkaruukun alusta